- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
Sort by:
Latest
|
Editors' Picks
|
Most Commented
|
Most Popular
-
Medical Device Trades: 7 Stocks Under 5 Bucks
-
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
-
FDA Calendar Updates: CombinatoRx, Covidien
-
FDA Calendar Updates: Novo Nordisk, Eisai, Acura, King and Myriad Pharma
-
FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences
-
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
-
FDA Calendar Updates: AMAG Pharma, Takeda
-
10 New Stock Indexes for Tracking Healthcare Trends
-
FDA Extreme Trades: 16 Stocks Under 5 Bucks
-
FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, HLUKY
-
FDA Calendar Updates: Cell Therapeutics, OncoGenex Pharma
-
FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS
-
FDA Calendar Updates: Amgen, Amicus, Oncothyreon and Medarex
-
Pending FDA Decisions: 20 Extreme Trades
-
Seven New Extreme Biotech Trades
-
Seven Laggard Biotech Trades
-
FDA Calendar Updates: BioDelivery Sciences Worth the Wait
-
FDA Calendar: 18 Hot Summer Trades
-
FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma
-
FDA Calendar Updates: BDSI, SVNT Deadlines Approach
-
Access Pharma: Preparing to Advance Pipeline
-
FDA Calendar Updates: Trinity Biotech Awaiting Two Responses
-
NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
-
Five Extreme Biotech Trades
-
FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
-
7 Extreme FDA Medical Device Trades
-
NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy
-
Emisphere: Improving Drug Delivery
-
FDA Calendar Updates: ABT, AFFY, AZN, LLY, MELA, PFE, SOMX, VPHM
-
FDA and Clinical Trial Updates: ADLS, CLDA, GENZ, ISTA, Theratech
-
13 Extreme FDA Trades
-
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
Latest Comments on Mike Havrilla's Articles